Original Article
Mean Change in Intra-Ocular Pressure
Following Trabeculectomy with Mitomycin C in Congenital Glaucoma
Wali Ullah, Omar Illyas, Mubashir
Rehman, Hina Khan
Pak J Ophthalmol 2018, Vol. 34, No. 3
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. .
.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See
end of article for authors
affiliations …..……………………….. Correspondence
to: Mubashir Rehman Department of Ophthalmology Hayatabad Medical Complex, Peshawar Email: drmubashirrehman78@gmail.com |
Purpose: To determine the
mean change in intraocular pressure after trabeculectomy with Mitomycin C
surgery in primary congenital glaucoma. Study Design: Quasi experimental
study. Place and Duration of Study:
Outpatient department of Ophthalmology Hayatabad Medical Complex,
Peshawar. From Jan 20, 2016 to June 20, 2016. Material and Methods:. Patients of both genders
between age of 0-6 years with PCG and IOP of 21 mm Hg or more with and
without topical anti-glaucoma medication were included in the study. Eyes
with complicated or traumatic cataract and previous ocular surgeries were
excluded from the study. Sample size was calculated by WHO software for
sample size calculation using 77.10 % proportion of decrease in IOP and 95%
confidence interval and a 7% margin of error. Diagnosis was confirmed by examination under general
anesthesia. All the surgeries were done by same ophthalmologist. 0.4 mg/ml of
MMC was applied below the flap for two minutes followed by copious
irrigation. Follow up visit was done on 14th post-operative day. EUA was
performed 2 months after surgery where the eye was examined for Bleb
morphology, leakage, infection or any other complication. Results: In this study 38
patients undergoing Trabeculectomy with Mitomycin C were followed. Out of 38
patients 24 were male and 14 were female. Average age was 1.49 ± 0.95SD
years. Average pre-operative intraocular pressure (IOP) was 29.81 ± 4.80 SD
while post-operative IOP was 17.21 ± 3.82 SD. Conclusion: Intraocular
pressure was decreased significantly in patients after Trabeculectomy with
Mitomycin C. Key words: Congenital glaucoma, Trabeculectomy, Mitomycin C. |
Glaucoma is the leading cause of irreversible blindness worldwide1.
It is considered the second most common cause of blindness affecting 60 million
people worldwide, with an estimated 8.4 million people blind due to glaucoma.
This overwhelming figure is set to increase to 80 million diseased and 11.2
million blind by 20202. In Pakistan, glaucoma is the fourth most
important cause of irreversible blindness3.
In infancy, Primary congenital glaucoma (PCG) is the most common
type of glaucoma with an incidence of 1 in 10,000 to 68,000 live births among
different ethnic populations. Worldwide PCG is responsible for about 18% of
children in institutions for the blind and 5% of overall pediatric blindness4.
The incidence of PCG in the Pakistani children is about nine times higher than
that in Caucasians3. The incidence of PCG varies when high rates of
consanguinity are present5.
Medical therapy plays only an adjunctive role to the main
treatment strategy, which is surgical management of congenital glaucoma. In
order to maintain best visual function before permanent structural changes
occur to the eye, surgery should be considered as early as possible4.
Successful control of IOP through surgical treatment is crucial to provide a
lifetime vision, in children with glaucoma6. In glaucoma surgery,
the resistance to the aqueous outflow due to structural abnormalities in the
anterior chamber angle are bypassed. Insertion of anterior ciliary body and
iris overlapping the trabecular meshwork and presence of non-permeable barkan’s
membrane over the trabecular meshwork are the main structural abnormalities in
the angle of congenital glaucoma patients7.
Regarding surgical options, trabeculectomy is an effective
treatment option in primary congenital glaucoma. It is however challenging in
children and because of a vigorous healing reaction, trabeculectomy is less successful
when compared with outcomes in adults7. This reduced surgical
success rate is due to postoperative proliferation of fibroblast and scarring
of the filtering bleb.
To prevent scarring of the filtration bleb numerous techniques
have been applied including application of anti-metabolites, anti-VEGF agents and
Beta radiation8. To improve the success rate, 5-fluorouracil and
Mitomycin C are most commonly used as a surgical adjunct to prevent bleb
scarring9. Mitomycin C (MMC) selectively inhibits DNA replication,
mitosis, and protein synthesis. The drug inhibits the proliferation of
fibroblasts, suppresses vascular in-growth. Optimum concentration and exposure
time are not known and vary between 0.2–0.5 mg/ml and 1–5 min10.
No proper data is available
regarding IOP control after trabeculectomy with MMC in our community. There is
limited local data available about the outcome of trabeculectomy surgery and
its effectiveness in decreasing intraocular pressure. The international data
available also shows a wide range of variance in decreasing intraocular
pressure after trabeculectomy with MMC. This study is designed to find out the
accurate mean decrease in intraocular pressure after trabeculectomy with MMC
locally. The data and results will be shared with the local consultants.
MATERIAL
AND METHODS
Patients attending the outpatient department of Ophthalmology
Hayatabad Medical Complex, Peshawar, of both genders between age 0 - 6 years
with PCG and IOP of 21 mm Hg or more with and without topical anti-glaucoma
medication were included in the study. Eyes with complicated or traumatic
cataract, previous ocular surgeries like repair, squint surgery, retinal
detachment surgery, cataract extraction etc., previous ocular trauma,
intra-operative vitreous loss, post-operative endophthalmitis and eyes which
received trauma postoperatively in the follow up period, were excluded from the
study.
Provisional diagnosis of congenital glaucoma was made in OPD after
initial examination of all children. Diagnosis was confirmed by examination
under general anesthesia. Both eyes were examined. The intraocular pressure was
measured first, using Perkins Tonometer. Horizontal corneal diameter was measured
with calipers. Gonioscopy was done with Swan Jacob goniolens. Further
evaluation including anterior segment examination, Fundoscopy and retinoscopy
(if the cornea was clear enough) was performed. The patient's condition was
explained to parents and consent obtained for surgery which was performed under
general anesthesia on the nearest available list. All the surgeries were done
by single consultant ophthalmologist.
A limbal-based conjunctival and tenon's capsule flap was made. A
rectangular (4×3 mm) partial thickness scleral flap was fashioned
supero-temporally/supero-nasally with 15 size blade or crescent knife up-to
clear cornea and 0.4 mg/ml of MMC was applied sub-conjunctively and below the
flap for two minutes followed by copious irrigation with Balanced Salt
Solution. Scleral flap was sutured using 10/0 nylon applied on corners of
scleral flap. Conjunctiva was closed with 10/0 nylon suture. Topical
combination of steroid and antibiotic medications was started on the first
post-operative day for 8 to 12 weeks.
Every patient underwent follow up visit on 14th post-operative day. EUA was performed 2
months after surgery where the eye was examined for Bleb morphology, leakage,
infection or any other complication, which can be related to surgery along with
afore-mentioned parameters.
Intraocular pressure was measured before surgery on the day of
surgery and 2 months after the surgery by Perkin’s tonometer to calculate the
mean change.
Total sample size was 38 which was calculated using Confidence Interval
(2 sided): 95%, Power: 90%, Mean Group 1: 27.40, Mean Group 2: 19.40, Mean
Difference: 08, Standard Deviation Group 1: 6.3, Standard Deviation Group 2: 8.5.
Data was analyzed utilizing
SPSS format of windows 20. For quantitative variables like age, preoperative
and postoperative intraocular pressure mean ± standard deviation was
calculated. Frequency and percentage were used for qualitative variables like
gender and eye involved. Comparison of pre
and post-operative intraocular pressure was done using Paired t test. To see
the effect modification, pre and post-operative IOP was stratified among gender
and age. To see the effect modification, post stratification pair t-test was
applied. P value < 0.05 was taken as significant.
RESULTS
38 patients undergoing
Trabeculectomy with Mitomycin C. were followed. In which 24 (63.15%) were male
and 14 (36.84%) were female patients. Male to female ratio was 1.71:1 (Table
1). Right eye was involved in 21 (55.26%) cases while the rest of 17 (44.73%)
patients had left eye involvement (Table 2).
Table 1: Gender wise distribution of patients.
Gender |
Frequency |
Percentage
(%) |
Male |
24 |
63.15 |
Female |
14 |
36.84 |
Total |
38 |
100 |
Table 2: Laterality (side) wise distribution of patients.
Eye
Involved |
Frequency |
Percentage
(%) |
Right |
21 |
55.26 |
Left |
17 |
44.73 |
Total |
38 |
100 |
Mean pre-operative intraocular
pressure (IOP) was 29.81 + 4.80 S.D while post-operative IOP which decreased in
patients after Trabeculectomy with Mitomycin C to 17.21 + 3.82 S.D and was
found highly significant with p-value < 0.003 (Table 3).
Table 3: Comparison of mean pre-op and post-op IOP
in total patients.
IOP (mm Hg) |
|
P Value |
||
N |
Mean |
Std. Dev |
||
Pre
op IOP |
38 |
29.81 |
4.80 |
< 0.003 |
Post
op IOP |
38 |
17.21 |
3.82 |
Paired
t- test applied
Stratification for
pre-operative and post-operative IOP with regards to age groups showed that
there was statistically significant lowering of IOP in both the age groups whether it was less
than or more than 1 year of age (Table 4). Similar pattern was found when the
pre-op and post-op IOP was stratified with regard to gender, as P-value was
less than 0.05 indicating significance. P-value for male and female was found
to be less than 0.003 and 0.005 in both the age groups respectively (Table 5).
Table 4: Stratification for pre-op and
post-operative IOP with regard to age groups.
Age Group |
N |
IOP |
Mean ±S.D |
P-value |
≤ 1year |
14 |
Pre-op |
30.07 ± 4.77 |
< 0.004 |
Post -op |
17.41 ± 4.11 |
|||
> 1 year |
24 |
Pre-op |
29.66 ± 4.73 |
< 0.005 |
Post -op |
17.08 ± 3.39 |
Table 5: Stratification for pre-op and
post-operative IOP with regard to gender.
Gender |
N |
IOP |
Mean ±S.D |
P-value |
Male |
24 |
Pre-op |
29.62 ± 4.94 |
< 0.003 |
Post -op |
17.41 ± 4.1 |
|||
Female |
14 |
Pre-op |
30.14 ± 4.73 |
< 0.005 |
Post -op |
16.85 ± 3.39 |
When pre-operative and
post-operative mean IOP was stratified with regard to eye involved it was found
significant statistically (P-value < 0.05) in both the right and left eye.
P-value for right eye and left eye was less than 0.005 and 0.002 respectively (Table
6).
Table 6: Stratification for pre-op and
post-operative IOP with regards to eye involved.
Side |
N |
IOP |
Mean ±S.D |
P-value |
Right |
21 |
Pre-op |
30.61 ± 4.77 |
< 0.005 |
Post –op |
17.53 ± 4.1 |
|||
Left |
17 |
Pre-op |
28.8 ±4.73 |
< 0.002 |
Post –op |
17.2 ± 4.3 |
DISCUSSION
Primary congenital glaucoma (PCG) is the leading
cause of blindness in infancy with an incidence of 1 in 10,000 to 68,000 live
births among different ethnic populations4. An imbalance of aqueous
production and aqueous outflow via the trabecular meshwork and the uveoscleral
pathway results in raised intraocular pressure. In congenital glaucoma, the
pathology lies in the trabecular meshwork which exhibits a developmental defect
leading to raised intraocular pressure11. The primary objective in
the management of primary congenital glaucoma is to prevent loss of visual
function and preserve the ocular integrityby normalizing and permanently
controling the intraocular pressure12.
Primary treatment option for treating congenital
glaucoma is surgical with medical therapy having only an adjunctive role.
Surgery should be considered as early as possible to prevent permanent visual
loss4.
Male predominance was seen in this study
accounting for 63.15% of cases. The literature showed a preponderance of males
in 65-80% of the cases13. Olusanva et al, in their study on outcome
of Trabeculectomy in congenital glaucoma had a male to female ratio of 3.5:1.
In their study the male population accounted for 77.7% of the total sample14.
However, in certain ethnicities the incidence of congenital glaucoma is more in
female gender. In Japan females are more affected, with a ratio of girls to
boys of 3:215.
Average pre operative intraocular pressure (IOP)
in this study was 29.81 + 4.80 SD while post operative IOP was 17.21 + 3.82 SD
which was decreased in patients after Trabeculectomy with Mitomycin C and found highly significant. Our results are
comparable to other similar studies. Essuman et al. reported the mean
pre-operative and postoperative intra-ocular pressures of 30.3 ± 8.8 mmHg and
18.1 ± 6.8 mmHg respectively following Trabeculectomy with Mitomycin C. The
difference between pre-operative and post-operative IOP in their study was
statistically significant16.
Postoperative fibrosis and scarring at the
surgical wound site is a known complication and a risk factor for failure of surgery.
Postoperative scarring may hamper the drainage of aqueous fluid from anterior
chamber through the artificial opening made during glaucoma drainage surgery17.
Mitomycin is an alkylating agent which reduces the fibroblast proliferation and
reduces the amount of scarring18. Susanna et al in their study
showed that the use of Mitomycin reduces post surgery fibrosis and attributed
to the favourable results in casess with adjuvant use of Mitomycin C19.
In more than 80% of cases, the onset of the
clinical profile of the disease appears during the first year of life, with 25%
diagnosed in the neonatal period and 60% during the first 6 months of life20.
In our study, the highest number of cases presented during the first year of
life accounting for 36.84% of the study cohort. One of the many possible
explanations to the problem is lack of patient education regarding the disease.
Advanced disease is a known risk factor for poor outcome in congenital glaucoma
which is often associated with poor visual prognosis. Nevertheless, late
presentation is a problem commonly encountered in developing countries21.
Olusanva et al reportedly had 50% of cases presenting after first year of life14.
We did not
encounter any patient for bleb revision or repeat surgery due to raised IOP in
our series. Moreover, for early postoperative bleb leaks we never had to use a
bandage contact lens, as described by some authors. There was no incidence of
choroidal effusion which is reported in 17-23% of cases in other studies22.
CONCLUSION
Trabeculectomy with Mitomycin C is a safe and effective method in
lowering intraocular pressure in cases of Primary Congenital Glaucoma. It is
helpful by reducing the intraocular pressure and in preventing further structural
changes to the eye and thus forestalling permanent visual disability. It is a
convenient and economical method to manage congenital glaucoma.
Author’s
Affiliation
Dr. Wali Ullah
MBBS, FCPS, FICO
(Ophthalmology)
Medical Officer
Type D Hospital, Kakki Bannu
Dr. Omar Illyas
MBBS, FCPS, FICO
(Ophthalmology)
Medical Officer
THQ, Tangi Hospital
Dr. Mubashir Rehman
MBBS, FCPS, (Ophthalmology)
Medical Officer
Department of ophthalmology,
Nowshera Medical College, Qazi Hussain Ahmad Medical complex, Nowshera
Dr. Hina Khan
MBBS, FCPS, (Ophthalmology)
Trainee Registrar
Department of ophthalmology,
Hayatabad Medical complex Peshawar
Role of
Authors
Dr. Wali Ullah
Patient’s selection, data
collection, results and discussion.
Dr. Omar Illyas
Patient’s selection, data
collection, results and discussion.
Dr. Mubashir Rehman
Patient’s selection, data
collection, results and discussion.
Dr. Hina Khan
Literature search.
REFRENCES
1.
Olawoye OO, Ashaye AO, Baiyeroju AM, Teng CC, Liebmann JM, Ritch
R. Outcomes of Trabeculectomy with
5-Fluorouracil at a Nigerian Tertiary Hospital. J Ophthalmic Vis Res. 2013; 8 (2):
126-33.
2.
Cook C, Foster P.
Epidemiology of Glaucoma: whats new? .Can J Ophthalmol. 2012; 47: 223-6.
3.
Bashir R, Sanai M, Azeem A, Altaf I, Saleem F, Naz S. Contribution
of GLC3A locus to Primary Congenital Glaucoma in Pakistani population. Pak J
Med Sci. 2014; 30 (6): 1341-5.
4.
Moore DB, Tomkins O, Ben-Zion I.
A Review of Primary Congenital Glaucoma in the Developing World. Surv Ophthalmol.
2013; 58: 278-85.
5.
Chang TC, Cavuoto KM.
Surgical Management in Primary Congenital Glaucoma: Four Debates. J Ophthalmol.
2013; 98: 134-9.
6.
Jayaram H, Scawn R, Pooley R, Chiang M, Bunce C, Strouthidis NG,
et al. Long-Term Outcomes of
Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years
of Life. Am. J. Ophthalmol. 2015; 122: 2216-22.
7.
Mahar PS, Memon AS, Bukhari S, Bhutto IA. Outcome of Mitomycin-C Augmented Trabeculectomy in Primary
Congenital Glaucoma. Pak J Ophthalmol. 2012; 28 (3): 136-9.
8.
Cheng JW, Cheng SW, Wei RL, Lu GC. Anti-vascular endothelial growth factor for control of wound
healing in glaucoma surgery. Cochrane Database Syst Rev. 2016; 15: 32-38.
9.
Ji QS, Qi B, Liu L, Lao W, Yang ZH, Wang GF, Yu GC, Zhong JX. Comparison of trabeculectomy and trabeculectomy with amniotic
membrane transplantation in the same patient with bilateral glaucoma. Int J
Ophthalmol. 2013; 6 (4): 448-51.
10.
Hafez MI. Trabeculectomy with
collagen matrix implantation versus trabeculectomy with mitomycin C application
for the treatment of primary congenital glaucoma. J Egypt Ophthalmol Soc. 2015;
108: 26–31.
11.
DeLuise VP, Anderson DR.
Primary infantile glaucoma (congenital glaucoma). Surv Ophthalmol. 1983; 28: 1-19.
12.
Mandal AK, Gothwal VK, Bagga H, Nutheti R, Mansoori T. Outcome of surgery on infants younger than 1 month with
congenital glaucoma. Ophthalmology, 2003; 110: 1909-15.
13.
Elder MJ. Congenital glaucoma in
the West Bank and Gaza Strip.Br J Ophthalmol. 1993; 77 (7): 413-6.
14.
Olusanya BA, Ugalahi MO, Malomo MO, Baiyeroju A. Trabeculectomy for congenital glaucoma in University College
Hospital, Ibadan: A 7 year review of cases. Niger J Ophthalmol. 2015; 23: 44-7.
15.
Dickens CJ, Hoskins Jr HD.
Epidemiology and pathophysiology of congenital glaucoma. In: Ritch R, Shields
MB, Krupin T. (editors). The glaucomas. 2a ed. St. Louis: Mosby; 1996.
16.
Essuman VA, Braimah IZ, Ndanu TA, Ntim-Amponsah CT. Trabeculectomy with Mitomycin C: outcome for primary congenital
glaucoma in a West African population. Eye (Lond) 2011; 25: 77-83.
17.
Ghate D, Wang X. Surgical
interventions for primary congenital glaucoma. Cochrane Database Syst Rev.
2015; 30: 1.
18.
Hsu CR, Chen YH, Tai MC, Lu DW.
Combined trabeculotomy-trabeculectomy using the modified Safer Surgery System
augmented with MMC: its long-term outcomes of glaucoma treatment in Asian
children. Graefes Arch Clin Exp Ophthalmol. 2018; 256: 1187-1194.
19.
Susanna R Jr1,
Oltrogge EW,
Carani JC,
Nicolela MT. Mitomycin as adjunct chemotherapy with trabeculectomy in
congenital and developmental glaucomas. J Glaucoma.
1995; 4 (3): 151-7.
20.
Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG. Glaucoma: medical diagnosis with therapy. United Kingdom:
Elsevier; 2009: 112-114.
21.
Jayaram H, Scawn R, Pooley F, Chiang M, Bunce C, Strouthidis NG, Khaw
PT, Papadopoulos M. Long-Term Outcomes of
Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years
of Life. Ophthalmology, 2015; 122: 2216-22.
22.
Schrieber C, Liu Y. Choroidal
effusions after glaucoma surgery. Curr Opin Ophthalmol. 2015; 26: 134-42.